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Malaria is a parasite infection affecting millions of people worldwide. Even though
progress has been made in prevention and treatment of the disease; an estimated 214
million cases of malaria occurred in 2015, resulting in 438,000 estimated deaths; most of
them occurring in Africa among children under the age of five. This article aims to review
the epidemiology, future risk factors and current treatments of malaria, with particular
focus on the promising potential of molecular farming that uses metabolic engineering
in plants as an effective anti-malarial solution. Malaria represents an example of how
a health problem may, on one hand, influence the proper development of a country,
due to its burden of the disease. On the other hand, it constitutes an opportunity for
lucrative business of diverse stakeholders. In contrast, plant biofarming is proposed
here as a sustainable, promising, alternative for the production, not only of natural
herbal repellents for malaria prevention but also for the production of sustainable anti-
malarial drugs, like artemisinin (AN), used for primary parasite infection treatments. AN,
a sesquiterpene lactone, is a natural anti-malarial compound that can be found in
Artemisia annua. However, the low concentration of AN in the plant makes this molecule
relatively expensive and difficult to produce in order to meet the current worldwide
demand of Artemisinin Combination Therapies (ACTs), especially for economically
disadvantaged people in developing countries. The biosynthetic pathway of AN, a
process that takes place only in glandular secretory trichomes of A. annua, is relatively
well elucidated. Significant efforts have been made using plant genetic engineering
to increase production of this compound. These include diverse genetic manipulation
approaches, such as studies on diverse transcription factors which have been shown to
regulate the AN genetic pathway and other biological processes. Results look promising;
however, further efforts should be addressed toward optimization of the most cost-
effective biofarming approaches for synthesis and production of medicines against the
malaria parasite.
Keywords: biofarming, malaria resistance, Artemisia annua, artemisinin, transcription factors, hormones, genetic
engineering
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INTRODUCTION
Malaria is a parasite infection that still affects millions of
people worldwide. According to the annual World Health
Organization (WHO) report (WHO, 2014b, Malaria World
Report), about 90% of all malaria deaths occur in Africa,
mostly among children under the age of five. Therefore, malaria
has been listed among the most significant causes of death
worldwide (WHO, 2014b; Malaria World Report). Malaria
is a protozoan disease, transmitted by mosquitoes of the
genus Anopheles. Among the four species of the Plasmodium
genus that provoke malarial infections in humans, most
cases relate to either Plasmodium vivax or P. falciparum; the
latter being the most common and responsible for almost
all of the deaths (White et al., 2014). Despite malaria being
eradicated from the USA, Canada, Europe, and Russia, its
incidence increased, especially in tropical countries, from
the ‘1970s through the ‘1990s of the last century. Since then,
new progresses in terms of prevention and treatment have
been developed, in an attempt to control and eliminate
the infection. However the number of affected people,
and deaths, still remain high, and the disease is currently
transmitted in 108 countries worldwide (Feachem et al., 2010;
Alonso et al., 2011). There are three major reasons for the
high persistency of malaria. First, the onset of resistance
to anti-malarial drugs: the Plasmodium parasite developed
resistance to different treatments, especially when only a
single drug, quinine, was being administered (White and
Olliaro, 1996). This evidence pushed toward the search for
new treatments, while WHO (2008) suggested the use of
“combination therapies” to treat malaria. The discovery of
AN, an anti-malarial compound found in A. annua, and its
use in the “combination of anti-malarial treatments” (ACT),
has guaranteed a very powerful and efficacious ACT. Indeed,
the Nobel Prize in Medicine 2015 has been recently awarded
to, among others, Professor Youyou Tu for her discovery of
this anti-malarial compound. Despite this, two main issues
related to ACT still remain unresolved. Production cannot
cover the increasing demand in countries where the disease
is endemic, while the cost of these drugs is very high for the
people who need it the most. Plant molecular farming combines
agriculture and metabolic pathway engineering, exploiting the
plant’s natural biochemical pathways. In this context plant
biofarming would constitute a better cost-effective and valuable
system for producing huge amounts of AN, and thereby
improving the social-economic conditions of malaria-affected
areas.
A second cause of malaria’s persistency is climate change
and migration. These phenomena interact with environmental
factors, causing an increase in the distribution and impact
of malaria in endemic countries and an emergence in non-
endemic ones (Lindsay and Thomas, 2001; Reiter et al., 2004;
Lindsay et al., 2010; Caminade et al., 2014; Roiz et al.,
2014). During the early part of the 21st century, invasive
mosquitoes became widely established across Europe and, for
example, malaria reappeared in Greece (Danis et al., 2011,
2013). In addition, pyrimethamin-resistant parasites moved from
Southeast Asia, spreading resistance alleles across Africa (Roper
et al., 2004). Therefore, analyzing the socio-environmental
changes and monitoring migration have become critical tools
for keeping the malaria alert alive, even in countries where the
presence of this, and other, airborne diseases is absent or almost
undetectable.
Finally, a relaxation by health authorities in terms of
controlling the spread of the disease has been observed in
recent years. In areas where infection is unstable or confined
to a period of a few months, a burst of infection may occur –
due to climatic or social changes and mixed with a lack of
prevention and health care. Consequently, this symptomatic
disease, which can occur at all ages, could possibly cause
epidemics. As a result, untreated and improperly treated
malaria cases may lead to excessive malaria mortality and
morbidity.
This review will offer a panoramic view of the onset
of drug resistance, which constitutes a major threat against
malaria treatment and, hence, its eradication. Additionally,
attention will be paid to evaluating and elucidating the
contribution and impact of different A. annua biofarming
approaches, for improving drug production and decreasing
its price. This evaluation will include not only promising
results but also weaknesses and technological gaps, in an
attempt to optimise these approaches and improve the living
and working conditions of the inhabitants of the affected
areas.
MALARIA LIFE CYCLE, PREVENTION
AND TREATMENT
The stages of the malaria parasites’ life cycle have been
recomposed, like a puzzle, through the time, considering that
findings have not proceeded in a linear way. This complex history
is accurately described in a review by Cox (2010). Updated
information about the malarial cycle and disease was taken from
White et al. (2014) and is summarized in Figure 1. Female
Anopheles mosquitoes are responsible for the transmission of
malaria because they feed on blood (mostly at night), while
males feed on plant nectar. A mosquito that is hosting the
Plasmodium transmits malaria by the inoculation of motile
sporozoites into the blood of a vertebrate host, and the disease
is provoked by the consequences of red-cell parasitisation and
destruction. Severe malaria is provoked by massive sequestration
and destruction of red blood cells, then finally affects vital
organs and causes death. For the purpose of this review,
we have summarized all the data in a schematic description
(Figure 1).
The development of a malaria vaccine has been a very
challenging task, especially because of the nature and evolution
of the Plasmodium infection. In 2015, the European Medicines
Agency’s Committee for Medicinal Products for Human Use
(EMA-CHMP) expressed, for the first time, a positive scientific
judgment in favour of a potential anti-malarial vaccine, the
RTS,S/AS01. Its benefits outweigh the risks in the age groups
examined and this vaccine may be used in high-transmission
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FIGURE 1 | Lifecycle of Plasmodium falciparum (adapted from Cox, 2010). The cycle starts when a mosquito inoculates motile Plasmodium sporozoites,
which then move from the dermis to the liver, through the bloodstream. The sporozoites invade the hepatocytes and proliferate. One week after, the liver schizonts
burst, releasing a great number of merozoites into the bloodstream. These invade the erythrocytes and start the asexual cycle, with some parasites developing into
male and others into female gametocytes (precursors of gametes). After feeding, the Anopheles mosquito ingests the gametocytes from the blood. Once inside their
vector, they can reproduce sexually, originating in an ookinete and then an oocyst. The oocyst bursts, releasing sporozoites, which migrate to the salivary glands and
the cycle is complete.
areas in which mortality is very high. Unfortunately, the vaccine’s
efficacy is limited and it does not offer complete protection
(WHO’s Initiative for Vaccine Research; Agnandji et al., 2011;
RTS,S and Clinical Trials Partnership, 2012; European Medicines
Agency press release, 2015). Therefore, complementary and
sustainable strategies are still of paramount importance in
reducing the incidence of malaria. These approaches include a
combination of physical (mosquito nets) and chemical/biological
(repellent oils) measures, as well as increased access to A. annua
for first-line treatments against the disease. Unfortunately,
prevention does not suffice for eradication of malaria and
some efficient treatments have also been successfully used to
cure severe cases of malaria in recent decades. However, two
main issues still exist: the high cost of antimalarial drugs,
which the majority of the population in developing countries
cannot afford to pay, and the increasing drug-resistance that
the Plasmodium parasite has developed (Verdrager, 1995; White
and Olliaro, 1996). Uncontrolled drug distribution and use,
and phenomena such as migratory events and climate changes,
have contributed to the development of drug resistance. This
is the reason why WHO first recommended the use of a
combination of anti-malarial treatments as ACT, based on
AN, (WHO, 2008) as an attempt to avoid, or at least reduce,
parasite resistance. Unfortunately, improper, widespread use or
incorrect prescription management may increase the insurgence
of disease resistance (White, 2004; Gbotosho et al., 2009), having
a devastating effect on worldwide malaria control. ACT was
restricted only to the most difficult cases of malaria but, in
2010, the WHO changed its policy and authorized the use of
ACT as first-line treatment at a global level. Major concern
was provoked by data indicating that AN resistance had already
emerged in small areas of Cambodia, Thailand, Vietnam, and
Myanmar (Denis et al., 2006; Noedl et al., 2008; Dondorp
et al., 2009; Rogers et al., 2009; Carrara et al., 2013; Leang
et al., 2013; Saunders et al., 2014; Tun et al., 2015). This
Southern Eastern Asia area may be a possible route for the
spread of resistance to the Indian subcontinent (Gething et al.,
2011); the same path as that followed by chloroquine in the
past (Wellems et al., 2009; Ashley et al., 2014). This evidence
raised the level of alarm and the WHO quickly started a
campaign in the areas hit by AN resistance, attempting to
control the spread and understand how far it had reached.
So far, the spread has not affected Africa (Amaratunga et al.,
2012; Lopera-Mesa et al., 2013; Ashley et al., 2014; Mok et al.,
2015). Fortunately, real-time detection and monitoring of the
distribution of drug-resistant malaria parasites can help to
prevent the spread (Miotto et al., 2014; WHO, 2014a, Status
report on artemisinin resistance, Menard and Ariey, 2015; Tun
et al., 2015).
FROM TRADITIONAL MEDICINE
TOWARD BIOFARMING
Malaria inflicts a huge economic burden on individuals and
entire communities in developing countries. As a consequence,
the high prevalence of malaria in the poorest countries should
be a global health priority for the foreseeable future (Sachs and
Malaney, 2002; Chima et al., 2003; WHO, 2014b, Malaria World
Report).
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FIGURE 2 | Pharmacopoeia evolution across time. In recent centuries, pharmacopeia has developed from traditional medicine toward into plant biofarming,
which integrates the use of traditional medicine with modern medicine; therefore becoming an effective and sustainable approach for improving the well-being and
health of a community. Since the use of native medicinal plants and home-made herbal extracts, derived from ethno-botanical local plants, pharmacopeia has
moved toward the extraction of useful essential oils and other active compounds with healing properties. Finally, plant molecular pharming has been proposed as a
real alternative to chemically synthesized molecules and microbial and mammalian cell bioreactors.
Malaria prevention is one of the most cost-effective
interventions available (White et al., 2011). Indeed, the cost-
effectiveness of the different malaria treatments has improved
significantly in recent years, using measures for prevention such
as the aforementioned mosquito nets and repellents. But this
also might be improved upon by the introduction of biofarming
and exploitation of plant-based-drugs and different traditional
medicines. Indeed, the use of traditional medicine in tandem
with modern medicine has been identified as one of the main
factors that could explain the significant improvements of health
and social indicators in several developing countries (Simpson,
1988; Waxler-Morrison, 1988; Follér, 1989; Montenegro and
Stephens, 2006).
Historically, local pharmacopeia based on native medicinal
plants had been adopted by human beings even before society
was created (Fernandez, 2006). Since then, pharmacopeia
has passed through its own evolution process, starting with
ethno-botanical local and home-made medicines, derived
from basic herbal extract compounds, followed by chemically
synthesized pharmaceutical molecules, and reaching nowadays
plant biofarming processes (Figure 2). Plant molecular farming
combines metabolic pathway engineering and agriculture, in
order to use plants as factories and produce valuable products
such as recombinant proteins, vaccines or pharmacological
molecules (Thomson, 2008; Rybicki, 2014). Indeed, plant
biofarming represents an intriguing alternative to microbial
and mammalian cell bioreactors. The use of plants instead
of microbial and animal cells can significantly reduce the
production costs (Webster, 2004). Moreover, most of the
molecules produced in plants can be safely stored for long
periods without refrigeration, if they are expressed in seeds or
leaves that can be stored dried (Ahmad et al., 2012). Therefore,
plant biofarming represents an unprecedented opportunity to
manufacture affordable modern medicines and make them
available at a global scale, particularly in underdeveloped
countries where access to medicines and vaccines has historically
been limited (Murphy, 2007). Consequently there is an
increasing interest in the application of plant biofarming
to producing indigenous plant-derived medicines, as well
as in the identification of unique medicinal plants and
the discovery of new pharmacological active compounds.
Traditional plant-based medicines that have been genetically
improved for prevention and treatment of malaria represent
an appropriate example of biofarming and will be described
below.
MALARIA PREVENTION AND
TREATMENT USING PLANT-BASED
MEDICINES
Hundreds of plants have been identified around the world
as potential repellents against diverse types of mosquito.
Some of these natural herbal repellents may prevent the
bite of Anopheles, which is the transmission vector of
the malaria parasite (Gupta and Rutledge, 1994). Indeed,
research analysis conducted in the past revealed that, among
different plants, those that were most used as Anopheles
mosquito repellents were Neem (Azadirachta indica), Ocinum
gratissinum, Ocinum suave, Eucalyptus camaldulensis, Lantana
camara, and Lippia uckambensis (Seyoum et al., 2002a,b;
Dugassa et al., 2009; Kebede et al., 2010), as reported in
Table 1.
Due to their easy processing, efficiency and reduced cost,
these indigenous herbal repellents, if properly used, could
become a useful and sustainable approach for reducing
malaria-related infections and deaths (Mishra et al., 1995;
Ansari and Razdan, 1996; Okumu et al., 2007). Despite
this, molecular biofarming has not yet been applied to any
of these species. It could be a useful tool for increasing
the repellent content of the plant and, thereby, optimize
the efficacy of its anti-malarial properties. Consequently,
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future efforts may focus on the potential of molecular
farming for improving the repellent activity of these
plants.
Unfortunately, as prevention alone is not enough for the
eradication of malaria, treatment has become a crucial approach
for prevention of death. Some efficient treatments have been
used in recent decades; however, in most of the countries
where malaria existence was reported, the malaria parasite
developed resistance to quinine (White and Olliaro, 1996).
Quinine is a substance isolated from the peruvian trees Cinchona
calisaya and Cinchona succirubra and was used for almost
four centuries as the main drug for malaria treatment. Plant-
derived products keep making huge contributions toward the
fight against malaria, either as known, direct, anti-malarial
agents or as potential, and more efficient, novel anti-malarial
compounds (Kumar et al., 2009). Indeed, not only the
Cinchona tree but other plants species have also been found
to have pharmacological properties against the malaria parasite
(Table 1). This is the case of an herbal remedy based on
three plants: Cochlospermum planchonii, Phyllanthus amarus,
and Cassia alata (Kaushik et al., 2015; Lamien-Meda et al.,
2015). C. planchonii roots alleviate malarial symptoms, while
P. amarus and C. alata leaves and aerial tissues have anti-
malarial activity. Moreover, the active compounds of these
three plant species are able to act synergistically as a proper
anti-malarial phyto-medicine (Kaushik et al., 2015; Lamien-
Meda et al., 2015). Similar results have been found within
the diverse range of indigenous Amazonian plants so far
studied: Aspidosperma rigidum, Ampelozizyphus amazonicus,
Bertholletia excels, and Simaba cedron have all been found
to contain the most active anti-malarial extracts among the
amazon plants tested to date (Frausin et al., 2015; Oliveira
et al., 2015) (Table 1). Interestingly, it is not only species
in the Asiatic and Amazonian sub-areas, but Sub-Saharan
Africa’s enormous plant biodiversity is also proving to be a
source of new anti-malarial phyto-remedies. Useful chemical
compounds, with anti-plasmodial activity, efficacy and safety
TABLE 1 | Table showing the different medicinal plants used for preventing
and treating malaria all along the history.
Most used medicinal plants used to prevent malaria
Neem (Azadirachta indica) Eucalyptus camaldulensis
Lantana camara Lippia uckambensis
Ocinum gratissinum Ocinum suave
Medicinal plants used for malaria treatment
Adansonia digitata Ampelozizyphus amazonicus
Artemisia annua Aspidosperma rigidum
Azadirachta indica Bertholletia excels
Ficus sur Cassia alata
Cassia occidentalis Cassia siamea
Cinchona calisaya Cinchona succirubra
Cochlospermum planchonii Plumbago Zeylanica
Simaba cedron Tithonia diversifolia
Turraea robusta Turraea nilotica
Vernonia amigdalina
have been found in endemic plants growing in this area,
including Adansonia digitata, Azadirachta indica, Ficus sur,
Cassia occidentalis, Cassia siamea, Nauclea latifolia, Plumbago
Zeylanica, Tithonia diversifolia, Turraea robusta, Turraea nilotica,
and Vernonia amygdalina (Chinsembu, 2015; Irungu et al., 2015).
However, excluding quinine, due to the insurgence of resistance
to it, and all the potential therapeutic plants already described,
nowadays the most widely used and efficient ACTs are those
combining natural AN or chemically AN-synthesized derivates,
such as artesunate and artemether (Ajayi et al., 2008; WHO,
2014b).
ARTEMISIA ANNUA PLANT FOR
TREATING MALARIA
Artemisinin is an anti-malarial compound that can only be found
naturally in A. annua. Knowledge of the medicinal properties
of this plant dates back to the year 168 B.C., when it was first
used as a medicinal tea infusion to treat intermittent fevers
(De Ridder et al., 2008). Since then, A. annua has been used
in traditional Chinese medicine to treat malaria and other
diseases (Heide, 2006). Due to its unique mode of action, AN
is effective against the asexual stage of the malaria parasite’s life
cycle (Fidock, 2010). Interestingly, AN is a potential therapeutic
agent not only against this parasitic disease but also against viral
diseases, the treatment of certain cancers and the reduction of
angiogenesis (Efferth et al., 2002; Singh and Lai, 2004; Romero
et al., 2005). AN has proven cytotoxic effects against different
types of cancer cells, such as breast, colon, renal, ovarian, prostate,
central nervous system, leukemia and melanoma cancer cells
(Efferth et al., 2002; Ho et al., 2014; Tang et al., 2015). The
drug uses diverse mechanisms, such as inducing cell cycle arrest,
promoting apoptosis, triggering cancer invasion and metastasis,
and preventing angiogenesis, in order to function (Ho et al.,
2014).
Chemically, AN is a sesquiterpene lactone compound, that is
produced and stored exclusively inA. annua trichomes; which are
small, isolated, epidermal protuberances on the surfaces of leaves
and represent the aerial organs of most vascular plants (Olsson
et al., 2009). Trichomes are involved in defending the plants
against insect herbivores, viruses, UV light and/or excessive water
loss (Traw and Bergelson, 2003). There are several different
kinds of trichomes, but they are mainly classified into non-
glandular and glandular (Traw and Bergelson, 2003). InA. annua,
non-glandular trichomes are involved in water absorption, UV-
light reflection and seed dispersal. Glandular trichomes have
the morphological peculiarity to synthesize, store, and secrete
large amounts of specialized and sometimes toxic secondary
metabolites, including AN, that protect the plant from predators
without interfering with normal plant growth (Wu et al., 2010;
Lange and Ahkami, 2013). Glandular secretory trichomes from
A. annua are formed from ten cells in five pairs; two basal cells,
two stalk cells, four sub-apical cells and two apical cells. AN
synthesis takes place in the sub-apical and apical cells, while
its accumulation is localized in the sub-cuticular space of the
trichomes (Duke et al., 1994; Ferreira et al., 1995; Olsson et al.,
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2009). A. annua is a plant that can be readily grown in many
environments. However, the AN content extracted from fresh
and/or dry leaves is extremely low (0.1–10 mg/g dry weight), as it
is only produced in the trichomes. On the other hand, despite the
modernization of different techniques, to chemically synthesize
the molecule makes the price too high for a significant number
of malarial victims; especially those in developing countries
where the malarial burden and impact are the greatest (Abdin
et al., 2003; Zeng et al., 2008; WHO, 2014a). In the last ten
years, the amount of ACTs produced and provided has increased
36-fold (WHO, 2014b). Unfortunately, production still cannot
cover the increasing demand of artemisinin-based therapies in
endemic countries. Therefore it is critical to improve the AN
yield in planta, and develop better methods for its production.
In order to realize this aim, biofarming has become an essential
tool for increasing the worldwide supply of AN in the last
decade.
ARTEMISIA ANNUA BIOFARMING
APPROACHES USING METABOLIC
ENGINEERING
A prerequisite for the success of any secondary metabolite
production using metabolic engineering is a deep understanding
of its synthesis at the genetic level. For this reason, biochemical
and molecular biological studies have been able to elucidate
the complete biosynthetic pathway of AN in A. annua; as
schematically reported in Figure 3. Genes encoding components
of this pathway are specifically expressed in the A. annua
trichomes located on leaves, floral buds, and flowers (Olsson
et al., 2009). Two molecules of isopentenyl diphosphate (IDP)
and one molecule of dimethylallyl diphosphate (DMADP) are
condensed by farnesyl diphosphate synthase (FDS) to obtain
farnesyl diphosphate (FDP). FDP, which generally serves as a
precursor for sesquiterpenes including AN, is then converted
into amorpha-4,11-diene through the activity of amorpha-
4,11- diene synthase (ADS), and this is the first step of AN
biosynthesis proper (Bouwmeester et al., 1999; Mercke et al.,
2000). Amorpha-4,11-diene is then oxidized in three steps to
artemisinic acid, through the action of amorpha-4,11-diene
12-hydroxylase (CYP71AV1), and a single cytochrome P450
monooxygenase (Ro et al., 2006; Teoh et al., 2006). Recent
reports have shown that a double bond reductase (DBR2) and an
aldehyde dehydrogenase (ALDH1) operate in the conversion of
artemisinic aldehyde to its dihydro form, and then into the direct
AN precursor dihydroartemisinic acid, respectively (Zhang et al.,
2008; Teoh et al., 2009). The final production step is considered
the result of a non-enzymatic, photo-oxidation reaction (Sy and
Brown, 2001; Covello, 2008; Brown, 2010). However, recent
results have proposed that a peroxidase enzyme or an alternative
series of oxidations (occuring exclusively in planta) may in fact
catalyze the crucial last reaction that converts the precursor into
the valuable AN molecule (Bryant et al., 2015).
Over the decades, significant efforts have been made to
increase AN production and reduce costs. Some progress, using
diverse biofarming approaches, has been made in terms of
increasing the production of this compound. This review will
analyze the approaches that have been used in great detail;
considering which were more or less successful, and identifying
their strengths and weaknesses.
Genetically Modified Fast Growing
Organisms
Nowadays, AN derivates produced through chemical synthesis
provide the basis for the most efficient ACTs treatments. Despite
this, chemical synthesis of AN is not economically feasible
because of the complexity and low yield of the process, in addition
to the high prices for the people in need. Therefore, the use
of genetically modified, fast-growing organisms, such as genetic
engineered Escherichia coli and Saccharomyces cerevisiae, have
arisen as a real alternative to chemical synthesis (Lindahl et al.,
2006; Zeng et al., 2008). These organisms represent the most
widely used heterologous hosts for the expression of enzymes and
reconstitution of natural plant product biosynthetic pathways, as
has been previously demonstrated for curcumin and piceatannol
production (Zhang et al., 2015a).
To further increase cost-effective AN production, metabolic
engineering strategies were used, overexpressing AN synthesis
enzymes in these microorganisms (Figure 3). Cloning and
transfer of the ADS enzyme in Saccharomyces cerevisiae allowed
for the production of the AN precursor amorpha-4,11-diene in
yeast (Lindahl et al., 2006). But the most successful strategy
using an S. cerevisiae bioengineering approach was accomplished
by combining different enzymatic steps (Ro et al., 2006). These
steps included the cloning of the farnesyl pyrophosphate (FPP)
biosynthetic pathway to increase FPP production, which is the
immediate precursor before entering the AN pathway proper.
This step was followed by reconstitution of the AN enzymes
(mainly ADS and CYPP450) in these FPP high-producer yeasts.
Even though a large amount of arteminic acid was produced,
the final desired product, AN, was not synthesized. Although the
AN biosynthetic pathway has been well investigated and great
progress has been made in terms of cloning biosynthetic enzymes,
the last step of this peculiar synthesis is not yet completely
understood. Due to these previous results, it could be suggested
that the last step is probably a typical plant non-enzymatic
reaction that cannot be inserted into fast-growing organisms.
Therefore, in yeast, AN biosynthesis reaches only production
of the precursor, artemisinic acid, which afterward needs to be
chemically converted into AN (Ro et al., 2006; Paddon et al.,
2013). The large amounts of artemisinic acid that have been
produced in yeast could be transformed into AN through semi-
synthesis and later purification processes, but with a consequent
increase in costs.
In addition to yeast manipulation, genetic engineering using
Escherichia coli was used as an alternative for AN production
in microorganisms. Indeed, the introduction of the mevalonate
pathway from S. cerevisiae into E. coli led to efficient production
of terpenoid precursors (Martin et al., 2003). Consequently,
E. coli might be used as a reliable system for the industrial
production of plant sesquiterpenes, considering that some results
obtained in the last decade have confirmed the potential of
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FIGURE 3 | Diagram showing the different biofarming alternatives used instead of AN chemical synthesis. (1) Use of genetically modified, fast growing
organisms, such as Escherichia coli and Saccharomyces cerevisiae, for AN production. (2) Nicotiana tabacum used as a model plant for molecular farming. (3) Plant
endogenous factors, such as phytohormones and external abiotic factors, positively affect both trichome proliferation and artemisinin biosynthesis.
(4) Crop-breeding and vegetative propagation used to obtain tissue with higher AN content (5) Use of transcription factors, that positively regulate artemisinin
pathway, as an approach for increasing the amount of this molecule in the plant. (6) Metabolic engineering of overexpressing endogenous enzymes of terpenoid
biosynthesis in A. annua. The artemisinin biosynthetic pathway occurs exclusively in the glandular trichomes of A. annua plant. Despite AN biosynthesis utilizes
carbon mainly from the mevalonate pathway in the cytosol, Farnesyl diphosphate (FPP), AN precursor, is partially synthetized in the plastid through a
non-mevalonate pathway. Therefore, redirection of the mevalonate pathway away from the cytosol, to plastid compartments, such as chloroplasts and mitochondria,
may be a novel approach for increasing significantly AN production.
this tool. When a few mevalonate enzymes were heterologously
expressed together with the ADS enzyme, this confirmed that
amorpha-4,11-diene was produced at high levels in E. coli
(Martin et al., 2003; Tsuruta et al., 2009). However, as was
observed with S. cerevisiae, no AN was produced at all, most
probably due to the fact that the final step in AN biosynthesis is a
plant-only, naturally occurring, reaction.
Considering all the results obtained from production of AN,
using microbial hosts such as S. cerevisiae and E. coli, it can be
concluded that further optimization is required to achieve the
optimal yield for industrial production. Despite production of
AN precursors in these organisms being higher than in wild-type
A. annua, expensive semi-synthesis and purification processes are
needed afterward. Consequently, it was worth exploring more
biofarming approaches, in order to improve the cost-effectiveness
of AN synthesis and thus reduce the current price of ACT (Ro
et al., 2006).
Nicotiana tabacum Biofarming
In recent years, special attention has been paid to the fact
that the last step of AN synthesis is not yet completely
understood. As stated earlier, it was hypothesized that it could
be a non-enzymatic photo-oxidation reaction (Sy and Brown,
2001; Covello, 2008; Brown, 2010). However, recent results have
proposed that a peroxidase enzyme, or an alternative series of
oxidations that occur exclusively in planta, may catalyze this last
reaction in the process that produces the valuable AN molecule
(Bryant et al., 2015). As a consequence of the partial failure using
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microbial hosts, and considering that this last step is likely to
be restricted to plants, a biofarming approach, using Nicotiana
tabacum, was introduced to overcome this limitation (Figure 3).
Nicotiana tabacum, or the tobacco plant, is characterized
by fast growth and high biomass production. Therefore it has
been already established as a model plant for molecular farming
(Kumar et al., 2012). Indeed, isoprenoid metabolic engineering
has already been accomplished in tobacco (Kanagarajan et al.,
2012; Kumar et al., 2012); strongly suggesting that efficient AN
production could be achieved in this way. When heterologous co-
expression of the AN biosynthetic pathway enzymes was carried
out in tobacco, a clear accumulation of dihydroartemisininc
alcohol, but not of artemisinic acid -the precursor to AN was
detected (Zhang et al., 2011). This result may be explained
by the cellular environment of the transformed tobacco plant.
This different cellular environment, in contrast to A. annua,
may favor biochemical reactions toward the reduction of AN
intermediates to alcohols instead of oxidation toward acids
(Zhang et al., 2011). Due to this unexpected limitation, further
studies taking into account: the nature of the target AN (a unique
sesquiterpene lactone); the variability of the possible precursors;
the presence of different key genes for regulation; and the cellular
environment of the plant used for biofarming should be taken
into consideration (Majdi et al., 2015). Current approaches in this
field have unfortunately obtained AN yields in tobacco that are a
thousand times lower than those obtained in A. annua (Paddon
et al., 2013). Additionally, chemical synthetic conversion of the
AN precursors produced in tobacco is still needed for the last
reaction. Therefore, further research in this field is essential, in
order to achieve proper cost-effectiveness of AN production.
Endogenous and Exogenous Factors
that Induce AN Production
Several factors also produced by A. annua have been found
to positively affect AN synthesis (Figure 3). Among these
endogenous factors, phytohormones play an essential role.
Some plant hormones, such as abscisic acid (ABA), gibberellins
(GA), salicylic acid (SA), and jasmonic acid (JA) have been
described as positively affecting both trichome proliferation and
AN biosynthesis in A. annua (Zhang et al., 2005, 2015b; Pu
et al., 2009; Yu et al., 2011) (Figure 4). JA regulates secondary
metabolism in several plant species (van der Fits and Memelink,
2000; De Boer et al., 2011) and, as expected, exogenous treatment
with JA also stimulates AN production in A. annua, as well
as formation of glandular trichomes (Baldi and Dixit, 2008).
Similarly, external application of ABA enhances AN production,
by stimulating the expression of several synthesis enzymes
(Zhang et al., 2009, 2015b). Furthermore, action of SA, a phenolic
plant hormone involved in plant development, transpiration,
ion uptake and transport, has also been implied in the plant’s
response to different abiotic/biotic stresses (Rao and Davis, 1999;
Bulgakov et al., 2002; Hayat and Ahmad, 2007). Generally, the
mechanisms of plant defense are related to the increase of H2O2
and reactive oxygen species (ROS) levels (Lamb and Dixon,
FIGURE 4 | Essential factors promoting AN biosynthesis. Endogenous and exogenous factors that positively affect AN biosynthesis. Different abiotic factors
inducing plant defense, trichome proliferation and, consequently, AN production. Seven transcription factors have been identified so far in the positive regulation of
any of the AN pathway enzymes. Plant hormones ABA, GA, JA, and SA also positively affect both trichome proliferation and artemisinin biosynthesis. Dashed,
colored arrows indicate TFs that directly regulate hormone biosynthetic pathways.
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1997; Ebel and Mithöfer, 1998). Some studies have revealed that
SA applications are able to increase AN content in A. annua
within a 54% in two different ways: firstly by converting the
dihydroartemisinic acid into AN, due to the burst of ROS, and
secondly by positively affecting the expression of both AN-related
biosynthetic enzymes (Pu et al., 2009).
According to these findings, GA is the hormone that plays the
most important role in promoting AN synthesis. In A. annua,
AN production may in fact increase around 300–400% after
exogenous GA treatment, which also positively affects trichome
proliferation (Paniego and Giulietti, 1996). Despite the AN and
GA pathways taking place in the cytosol and plastids respectively,
both of them are well interconnected: an excess of bioactive
GA has been described as resulting in carbon being diverted
toward an efficient AN production, (Zhang et al., 2005). This
assumption is supported by the fact that the levels of transcripts
of FDS, ADS and CYP71AV1 increase after GA treatment (Banyai
et al., 2011; Maes et al., 2011). Consequently, these promising
insights regarding exogenous GA application should be taken
into consideration as an important tool for future cost-effective
AN biosynthesis. Indeed, the GA biosynthetic pathway has been
extensively characterized, and most of the genes encoding for
the biosynthetic enzymes have been well studied in other plants
(Olszewski et al., 2002). Therefore, significant efforts should be
addressed toward this complex regulatory network that leads to
the final production of the bioactive form of GA. Surprisingly,
recent data has shown that GA biosynthetic inhibitors have an
interesting, direct, inhibitory effect on in vitro growth of the
malaria parasite (Toyama et al., 2012). Indeed, treatment with
GA inhibitors resulted in morphological changes in the parasite
membrane permeability that, if not reversed, fatally injured the
parasite (Toyama et al., 2012); revealing an interesting new role
for GA in the fight against malaria.
It is also known that AN levels increase with trichome number,
density, and maturation. Furthermore, it is known that hormones
also control these processes, even if in an independent manner.
On one side, ABA, JA, SA and mainly GA control trichome
proliferation, by regulating the expression of key A. annua
Transcription Factors (TFs) that control trichome initiation and
AN synthesis - a topic that will be discussed in detail later in this
review (Smyth et al., 1990; Dill and Sun, 2001; Kautz et al., 2014;
Tian et al., 2014). On the other side, these hormones also interact
with and directly control key enzymes of the AN biosynthetic
pathway (Figure 4).
Not only endogenous hormones but also other substances,
such as exogenous sugars, have a positive effect on AN
biosynthesis (Arsenault et al., 2010b). However, the role of
sugars in AN is complex and sometimes confusing. While
sucrose and glucose increase transcript levels of the main AN
biosynthesis enzymes, when fructose is added, AN content is
significantly reduced (Arsenault et al., 2010b). Additionally,
chemical substances such as arsenic, chromium and NaCl also
induce AN biosynthesis in A. annua (Paul and Shakya, 2013).
All these substances were found to significantly increase AN
biosynthesis, by affecting the regulation of some of the AN
biosynthetic pathway genes. Further evidence strongly suggests
that this AN increase is due to the fact that all these substances
induce stress in the plant (Paul and Shakya, 2013). Regarding this
effect, several reports have shown how exposure of A. annua to
different abiotic treatments can induce AN biosynthesis. Light,
low temperature, salinity, drought, heavy metals and/or other
abiotic compounds trigger the generation of active oxygen species
(AOS), facilitating the transformation from AN precursors to
AN (Wang et al., 2001; Guo et al., 2004; Qureshi et al., 2005;
Qian et al., 2007; Pu et al., 2009) (Figure 4). The assumption
that abiotic stress positively affects AN content in the plant
may be explained by the correlation with trichome function.
As previously mentioned, the function of both glandular and
non-glandular trichomes in A. annua is to defend plants against
different potential damaging factors using different mechanisms.
Consequently, we suggest that all these abiotic factors that are
found to increase AN content might be due, at least partially,
to an increase in the number of trichomes, as a defense
mechanism in response to this stress (Valkama et al., 2004; Wu
et al., 2006; Magnan et al., 2008; Sharma et al., 2011). This
physiological response may have an indirect effect in the case of
glandular trichomes, as this higher trichome density will increase
the quantity of secondary metabolites produced. Supporting
evidence to this end is that trichomes from many plant species,
including A. annua, are involved in defending plants against UV
light radiation (Traw and Bergelson, 2003), and previous studies
have shown how UV light may induce AN production (Rai et al.,
2011).
Plants protect themselves from UV stress by producing UV-
absorbing compounds, such as flavonoids in the leaf epidermis
and trichomes (Rozema et al., 1997; Kumari et al., 2009). Pre-
treating A. annua plant’s with UV-B and UV-C lead to slight
AN increases of 10.5 and 15.7%, respectively. This improvement
is not only due to trichome proliferation but also to the
alteration of the activity of most of the AN pathway enzymes
(Rai et al., 2011). However, considering the low increase in AN
production, together with the toxicological UV-C potential, this
pre-treatment is not recommended for commercial issues (Rai
et al., 2011).
Artemisia annua New Varieties and
Vegetative Propagation
Asexual, or vegetative, in vitro propagation is a technically easy
and cheap method of propagation, used in agriculture and
industry for large-scale production of high-value metabolites.
It has a several advantages over seed propagation: it retains
the genetic constitution of the plant type almost completely
and is a less time-consuming process. Moreover, different plant
cell cultures can be used for this purpose. So far, A. annua
cell propagation has been realized using different cell types. In
vitro propagation of A. annua hairy roots has given the best
results (Jaziri et al., 1995; Liu et al., 1997) (Figure 3). Hairy
roots are genetically stable and generally show better biosynthetic
potential for secondary metabolites compared with other tissues
(Majdi et al., 2015). Interestingly, root hair morphology shares
similar genetic regulation to that of trichomes, which may
somehow explain these positive results. Furthermore, in vitro
production of AN can be enhanced by treating cell cultures
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with different elicitors, such as 2,6-di-O-methyl-cyclodextrin
(DIMEB) or the aforementioned phytohormones JA, GA and SA
(Paniego and Giulietti, 1996; Durante et al., 2011; Majdi et al.,
2015). Unfortunately, despite the potential of these tools and the
significant effort that has been made regarding A. annua cell
cultures, none of these methods are commercially available.
During the last decades, A. Annua crop-breeding has
produced new varieties (Figure 3). Indeed, A. Annua varieties
can be sorted into two chemotypes: the high artemisinin
producers (HAPs) and the low artemisinin producers (LAPs)
(Brown and Sy, 2004, 2006). HAPs include such varieties as
Chongqing, Anamed, Artemis and 2/39 that produce more AN
than arteannuin B, another derivate from artemisinin acid but
without therapeutic value (Covello, 2008; Brown, 2010; Reale
et al., 2011). These varieties have an average AN content that is
twice that of wild type A. annua plants. Moreover, the University
of York’s Centre for Novel Agricultural Products (CNAP), has
recently registered a new HAP variety, Hyb8001R, which will
be commercialized in China. Contrarily, LAP varieties produce
more arteannuin B than AN and include different Iran and Meise
varieties. Some recent evidence supports the hypothesis that the
chemotype is determined mainly by the activity of the DBR2
enzyme activity, whereas HAP varieties show a much higher
activity of that enzyme than LAP varieties do (Yang et al., 2015).
In order to reach more economically feasible AN production,
further studies may focus on the creation of new A. annua
varieties with an AN content that is much higher than the present
varieties.
Unraveling the Artemisia annua
Transcription Factor Genetic Engineering
Network
Significant but insufficient advances have been made in terms of
metabolic engineering for cloning the AN pathway in tobacco,
yeast and bacteria (Figure 3). However, only a few studies
so far have been carried out to study the regulation of this
pathway by TFs-encoding genes. Since the first reports of
successful Agrobacterium-mediated transformation of A. annua
in the 1990s (Vergauwe et al., 1996; Banerjee et al., 1997), these
transformation protocols have been optimized (Han et al., 2005).
Generally, TFs regulate the expression of a certain number of
genes from specific and/or related pathways (Borevitz et al.,
2000); therefore loss and gain of the function of TFs has arisen as
a promising biofarming approach for more efficiently regulation
of secondary metabolite production (Verpoorte and Memelink,
2002; Petersen, 2007) (Figure 3).
In recent years, a few TFs have been characterized as
regulators of the transcriptome, for controlling and regulating
different enzymatic steps through AN biosynthesis (Figure 4).
AaWRKY1 was the first TF to be identified and characterized in
A. annua (Ma et al., 2009). The constitutive and trichome-specific
expression of AaWRKY1, driven by the promoters CaMV35S and
CYP71AV1, respectively, dramatically increases the transcript
levels of CYP71AV1, but does not clearly affect the transcription
levels of FDS, ADS, and DBR2 (Ma et al., 2009). Additionally, the
AaWRKY1 protein can bind the regulatory region of the ADS
promoter (Han et al., 2014). As a result, in these transgenic plants,
AN content is 1.8 times increased compared with wild-type
A. annua (Ma et al., 2009).
Other studies have revealed how other TFs, belonging
to the bHLH and AP2/ERF families; regulate biosynthetic
genes (Yu et al., 2011; Lu et al., 2013a; Ji et al., 2014; Tan
et al., 2015). AabHLH1 was isolated from a cDNA library
obtained from glandular trichomes in A. Annua. Transient
overexpression of AabHLH1 in leaves increases expression levels
of ADS and CYP71AV1, the two key enzymes, thereby positively
regulating AN biosynthesis. Indeed, biochemical analyses have
shown that AabHLH1 protein is able to bind in vivo with
the E-box cis-elements, present in both ADS and CYP71AV1
promoters (Ji et al., 2014). Among all the TFs families, the
best characterized in A. annua is the AP2/ERF family. Four
members of this family Ethylene Response Factor1 (AaERF1), Aa-
Ethylene Response Factor2 (AaERF2), Trichome and Artemisinin
Regulator1 (AaTAR1) and AaORA were found to also directly
affect the AN biosynthesis pathway (Yu et al., 2011; Lu et al.,
2013a; Tan et al., 2015). Two JA- and ethylene- responsive AP2
family members, AaERF1 and AaERF2, that are highly expressed
in A. annua inflorescences, are also able to increase twofold the
accumulation of AN and artemisinic acid when overexpressed
(Yu et al., 2011). In contrast, RNAi lines that partially silence
AaERF1 and AaERF2 decrease both content of both metabolites,
by directly controlling ADS, CYP71AV1 and moderately DBR2
transcript levels (Yu et al., 2011).
AaTAR1 plays an essential role, not only in regulating AN
biosynthesis but also in other biological processes. Similarly to the
other TFs described so far, AaTAR1 controls ADS and CYP71AV1
expression, by binding to their regulatory regions. WhenAaTAR1
is silenced, AN content is dramatically reduced and cuticular wax
distribution is altered (Tan et al., 2015). In addition, AaTAR1
controls both glandular and non-glandular trichome initiation
and development in A. annua. The last AP2/ERF member studied
so far, AaORA, positively regulates the transcript levels of ADS,
CYP71AV1, and DBR2, as well as AaERF1. As a consequence, AN
content in these plant lines is regulated as well (Lu et al., 2013a).
Interestingly, overexpression of AaORA increases the expression
levels of diverse genes involved in different, but still related,
physiological aspects - such as defense. Phenotypical analyses
demonstrate that the AaORA protein is a positive regulator of
resistance to Botryris cinerea, by modulating the expression of
defense marker genes such as PLANT DEFENSIN1.2 (PDF1.2),
HEVEIN-LIKE PROTEIN (HEL) and BASIC CHITINASE (B-
CHI) (Lu et al., 2013a). Simultaneously, it was found that AaERF1
also confers resistance to Botrytis cinerea by activating some of
the defense genes via the JA and ethylene signaling pathways in
A. annua (Lu et al., 2013b).
Recent results obtained using A. annua indicate that the
TFs identified so far, that function in AN regulation, may
be involved in regulating other biological and developmental
processes such as trichome proliferation. Since TFs from other
plant species are known to be specialized in the regulation of
protective secondary metabolite biosynthesis, they are also able
to affect phyto-hormone biosynthesis and signaling (Wolucka
et al., 2005; Tuteja, 2007; De Boer et al., 2011). There is clear
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correlation between AN biosynthesis and ABA signaling, as
well as overexpression of AaPYL9; an ABA receptor ortholog,
increases AN production (Zhang et al., 2015b). Moreover, it
has been shown recently how AabZIP1, a basic leucine zipper
TF, connects ABA signaling to AN accumulation (Zhang et al.,
2015b). As previously mentioned, JA-responsive AP2 family
members, AaERF1 and AaERF2, directly control expression levels
of ADS, CYP71AV1 and, to some extent, DBR2 (Yu et al., 2011).
Despite significant advances being made into the elucidation
of the complex genetic network controlling AN biosynthesis,
none of the strategies using loss and gain of TF function
has resulted in an efficient enough increase in AN content
to be considered for commercial purposes. This limitation
might be biochemically explained due to several facts, such
as transgenic gene silencing, enzymatic limiting-steps and
synthesis/degradation of other final products of the pathway that
compete with AN for precursor sources, for example arteannuin
B or other terpenoids (Bertea et al., 2005; Zhang et al., 2008; Teoh
et al., 2009). Therefore, further studies in this field are essential
for dealing with these issues and overcome these difficulties.
Terpenoid Enzymes Studies in
Artemisia annua
Due to these limitations, new studies have been conducted to
better elucidated the complex regulation of the AN biochemical
pathway. For decades, it was believed that FPP precursors
(DMAPP and two units of IPP) were only biosynthesized
exclusively in the cytosol via mevalonate from acetyl-CoA
(Covello, 2008; Arsenault et al., 2010a,b; Graham et al., 2010;
Kiran et al., 2010). However, recent results have revealed
that despite AN biosynthesis utilizes carbon mainly from the
mevalonate pathway, some of the carbon sources for AN
synthesis are also provided by plastids (Towler and Weathers,
2007; Schramek et al., 2010). Indeed, a non-mevalonate
biosynthetic pathway that occurs in plastids was also found
to be a source of terpenes in other plant species, via 1-
deoxyxylulose 5-phosphate and 2C-methylerythritol 4-phosphate
precursors (Rodriguez-Concepcion, 2006; Rohmer, 2007). In
addition, recent studies have provided evidences for metabolic
crosstalks between both compartments (Dudareva et al., 2005;
Skorupinska-Tudek et al., 2008; Schramek et al., 2010). A. annua
plants treated with specific inhibitors of mevalonate and non-
mevalonate pathway revealed that AN biosynthesis decreased
when used any of these inhibitors (Towler and Weathers, 2007);
concluding that both pathways are involved in AN formation.
Moreover, further studies suggested that DMAPP from cytosolic
mevalonate origin is transferred to the plastids, where one
of the IPP unit of non-mevalonate origin is used to form
geranyl diphosphate (GPP) (Schramek et al., 2010). Once GPP
is synthetized, it is exported again to the cytosol other IPP unit
but from mevalonate origin it is used to convert GPP to FPP
(Schramek et al., 2010).
Consequently, it has been hypothesized that, if carbon
resource comes from these two mevalonate and non-mevalonate
pathways, some key enzymes from this may also play essential
roles in regulating the synthesis and degradation of the final
products from the AN pathway. It is well known that for a specific
pathway that competes with another one for common precursors,
as in this case is the FDP availability, the accelerated conversion
of this precursor to the product of interest, using genetic
engineering, may minimize the conversion of the precursor to
other competing molecules (Majdi et al., 2015). During the
past years, a few rate-limiting endogenous enzymes involved in
terpenoid biosynthesis have been overexpressed (Figure 3). This
was the case with FPS or isopentyl transferase (IPT) enzymes
from A. annua and FDP synthase from Gossypium hirsutum
that were cloned and overexpressed in A. annua (Chen et al.,
2000). However, and similar to considering the loss and gain
of function of TFs, when these enzymes were constitutively
overexpressed in the plant, the highest AN content in these
transgenic plants was increased two- to three-fold (Ma et al.,
2009; Liu et al., 2011; Han et al., 2014). These results indicate,
once again, that AN biosynthesis might be strongly regulated by
other unknown factors. Indeed, similar evidence was obtained
when the expression of squalene synthase and β-caryophyllene
synthase – enzymes that compete for FDP with ADS was
repressed: A. annua plants in which these enzymes were silenced
showed a 1.5- to 2-fold increase in AN content (Wang et al.,
2012).
Fortunately, when the cellular mevalonate pool and its
channelization toward AN biosynthesis was enhanced by
overexpression of the enzyme 3-hydroxy-3-methylglutaryl
coenzyme A reductase (HMGR), a much better result was
obtained (Alam and Abdin, 2011). HMGR is considered to
be the rate-limiting enzyme of the mevalonate pathway, that
converts HMG-CoA to mevalonic acid at the beginning of
isoprenoid biosynthesis in the cytosol (Chappell, 1995; Argolo
et al., 2000). Mevalonic acid serves as the common precursor
for the synthesis of different secondary metabolites, including:
sesquiterpenoids, triterpenoids, sterolsand phytoalexins, from
different plant species (Chappell, 1995; Argolo et al., 2000;
Ayora-Talavera et al., 2002). When HMGR from Catharanthus
roseaus was overexpressed, together with ADS, in transgenic
A. annua plants, AN content increased 7.65-fold (Alam and
Abdin, 2011). This result strongly suggests that it is crucial to
take into consideration other limiting-rate factors, upstream
in the pathway, in order to divert as much carbon resources
as possible toward AN biosynthesis. Indeed, the latter strategy
was also used in tobacco and showed promising results. When
different enzymes, including not only HMGR but also those
involved in AN synthesis, were overexpressed in tobacco, AN was
finally produced for the first time in another plant (Farhi et al.,
2011). Interestingly, in these transgenic tobacco plants, ADS was
not only expressed in the cytosol but also in the mitochondria,
using a COX4 transit peptide; suggesting the potential of plastid
transformation.
BIOFARMING ARTEMISIA ANNUA
FUTURE STRATEGIES
There is great concern among the international health
community regarding the onset of AN resistance in the
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malarial parasite. Even though synthesized AN has been in
use for less than 20 years, the first cases of parasite resistance
have been already identified. However, A. annua tea has
been used in china for the last 1000 years without any
resistance development. This could be explained by the fact
that artificial AN has sometimes been wrongly used as a
monotherapy, while A. annua, in addition to AN, contains
other anti-malarial substances, such as artemetin, casticin,
cirsilineol, chrysoplenetin, sesquiterpenes, and flavonoids.
These compounds work in synergy with AN, reducing the
possibility of the parasite developing resistance (Willcox,
2004). Moreover, it has also been proven that an A. annua
infusion has the additional effect of strengthening the immune
system, which could bring extra benefits to local people in areas
affected by malaria (Willcox et al., 2005). The synergic action
of the different compounds in A. annua suggests that special
attention should be directed toward plant biofarming in the
future.
Some of the brightest prospects for the success of the
plant biofarming field include the plant-made viral vaccines,
or desired peptides, that are the earliest products of this new
technology (Viana et al., 2012; Rybicki, 2014). The success
of these approaches is not only based on the production
rate increase of the desired molecule but also on the
reproduction of desirable post-translational modifications that
reduce the risk of allergenicity (Viana et al., 2012). Unfortunately,
early molecular biofarming approaches, based on genetic and
metabolic engineering, to increase AN content in different
plants and microorganisms have not been as effective as
was expected. However, recent reports have highlighted new,
promising insights for finally reaching a more cost-effective
approach. Genetic and metabolic engineering studies indicate
that, despite AN biosynthesis being strictly regulated, it is still
possible to modulate it using external factors as well as genetic
ones. External application of diverse plant phytohormones,
specially GA, or sugar concentrations, together with abiotic
factors, could optimize AN production. However, recent results
concerning AN production using genetic engineered plants
evidence the enormous potential of biofarming for obtaining
economically feasible AN synthesis. At the gene level, and similar
to biosynthesis of other plant secondary metabolites (Zhang
et al., 2015a), overexpressing only the full AN pathway was
not sufficient for a significant increase in AN production, and,
therefore, rendered AN production in plants uneconomical.
This limitation in AN production might be explained by
some enzymatic limiting-steps, as well as by competition for
precursor sources with other terpenoids, or AN-derivatives, such
as arteannuin B. Further studies that have been conducted
addressing these issues have revealed promising results. Indeed,
evidence has recently shown that the mevalonate pathway could
be one of the most efficient biopharming approach used so far
to increase AN production using genetic engineering. As strong
competition exists among the different pathways for the available
mevalonate products, it is therefore crucial to take the rate-
limiting factors of carbon diversion, as Alam and Abdin (2011)
have proved, into consideration. By overexpressing HMGR and
ADS, the rate-limiting enzymes of the mevalonate and AN
pathways respectively, A. annua plants increase AN content
more seven-fold; something that has not been achieved using
any other strategies. This evidence suggests that, nowadays,
A. annua biofarming is finally starting to optimize strategies for
production of effective bioengineering AN. Therefore, further
research should be addressed toward key-limiting enzymes from
other terpenoids precursor sources from either mevalonate or
non-mevalonate pathways.
There is also a growing interest in applying proteomics and
genomics to A. Annua, but one of the biggest handicaps of
these techniques is the lack of availability of well-annotated
databases. The in silico comparison of different A. annua
databases, including: the EST trichome library; A. annua
trichome Trinity contig database; Uni/Prot/A. annua; and
UniProt/viridiplantae, have been useful tools for identifying
important enzymes and TFs. However, these tools have
also revealed significant differences in their suitability for
genomic and proteomic analyses. Despite these differences,
the EST trichome library has allowed identification of
essential proteins, enriched in the A. annua trichomes,
that are involved in biosynthesis and regulation of AN,
as well as other related enzymatic processes (Bryant et al.,
2015). Fortunately, the imminent release of the entire
genome of A. annua will resolve this challenge, provide
benefits to the scientific community and offer a better
understanding of the genetic machinery regulation for AN
production.
Finally, further biofarming efforts should be addressed
toward different physiological aspects, such as different plant
cell systems and compartments that might be used for large
scale production of AN or other useful metabolites. As with
many other metabolites of high pharmaceutical value, AN
is toxic to the plant itself, as it is able to inhibit cell
division and tissue growth (Dayan, 1998). AN is therefore
exclusively produced in the glandular trichomes of A. annua,
since these are independent compartments that are isolated
from the rest of the plant. Specifically, the expression of
the AN enzymes is active in both apical and subapical cells
of the trichomes, while AN and its precursors accumulate
in the subcuticular cavity of the glandular trichomes. Future
biofarming strategies should also, therefore, pay particular
attention to the initiation and development of trichomes. Genetic
engineering might be also used as a useful and sustainable
tool for AN production, by modifying diverse physiological
aspects of the trichomes, such as leaf area, trichome number,
density and alteration of the morphology of different cell
types that form glandular trichomes. In conclusion, it is
essential to keep in mind the use of different subcellular
compartments, such as plastids, that could be used as efficient
tools to exponentially elevate AN production in different plant
species. Studies of different plant species have further revealed
that redirection of the mevalonate pathway away from the
cytosol, to plastid compartments, such as chloroplasts and
mitochondria, is a new and potent approach for increasing
sesquiterpene production from 100–10,000 times (van Herpen
et al., 2010; Liu et al., 2011). The expression of foreign
genes in the chloroplast also allows there to be almost 10,000
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genome copies per cell, without the need for a signal peptide or
no-gene-silencing possibility, (Bendich, 1987; Hasunuma et al.,
2008; Kumar et al., 2012). Consequently, this novel biofarming
approach, if properly used, may have enormous potential for
economically feasible and sustainable AN production.
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